The role of FOXM1 and PD-L1 in malignant peripheral nerve sheath tumor resistance

A new mini review was published in Oncotarget’s Volume 15 on September 30, 2024, entitled, “Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors.”

Weight loss MEAI: Clearmind Medicine’s Novel Obesity Drug Showed Positive Results in a Pre-Clinical Trial | Psychedelic Invest

Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to

December 1, 2023

Endocrine Disruptors in Paper Straws; Wegovy’s CV Benefit; Stroke and Infertility Tx

Eco-friendly paper and bamboo straws were found to have much higher levels of the endocrine-disrupting chemicals PFAS than straws made out of other materials. Researchers

September 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

The role of FOXM1 and PD-L1 in malignant peripheral nerve sheath tumor resistance

Weight loss MEAI: Clearmind Medicine’s Novel Obesity Drug Showed Positive Results in a Pre-Clinical Trial | Psychedelic Invest

Study uncovers probable origin of stuttering in the brain

Endocrine Disruptors in Paper Straws; Wegovy’s CV Benefit; Stroke and Infertility Tx

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe